Vericel (VCEL) Misses Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Vericel Corporation (VCEL) PT Lowered to $45 at BTIG
February 24, 2022 12:54 PM ESTBTIG analyst Ryan Zimmerman lowered the price target on Vericel Corporation (NASDAQ: VCEL) to $45.00 (from $50.00) while maintaining a Buy rating.
The analyst commented, "We maintain our Buy rating but lower our PT to $45 (from $50) as multiples have compressed in high-growth MedTech. VCEL reported 4Q21 revenue of $47.6M (+5.2% Y/Y) which was below BTIG/Consensus original expectations of $50.7M/$51.0M with the... More
